LLY |
Eli Lilly and Company |
0 |
7.40% |
|
|
|
|
|
N/A |
0.00% |
31.52% |
13.50% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
5.23% |
|
|
|
|
|
N/A |
0.00% |
27.37% |
15.71% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
5.01% |
|
|
|
|
|
N/A |
0.00% |
38.65% |
25.91% |
---|
BBIO |
BridgeBio Pharma, Inc. |
0 |
4.44% |
|
|
|
|
|
N/A |
0.00% |
55.58% |
16.37% |
---|
4519.T |
CHUGAI PHARMACEUTICAL CO., LTD. |
|
3.98% |
|
|
|
|
|
|
|
|
|
---|
ASND |
Ascendis Pharma A/S |
0 |
3.84% |
|
|
|
|
|
N/A |
0.00% |
45.09% |
33.37% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
3.82% |
|
|
|
|
|
N/A |
0.00% |
72.12% |
60.46% |
---|
AZN.L |
ASTRAZENECA PLC |
|
3.71% |
|
|
|
|
|
|
|
|
|
---|
NOVO-B.CO |
NOVO NORDISK A/S |
|
3.39% |
|
|
|
|
|
|
|
|
|
---|
CYTK |
Cytokinetics, Incorporated |
0 |
3.29% |
|
|
|
|
|
N/A |
0.00% |
54.73% |
17.73% |
---|
AMGN |
Amgen Inc. |
0 |
3.28% |
|
|
|
|
|
N/A |
0.00% |
23.72% |
11.87% |
---|
DXCM |
DexCom, Inc. |
0 |
3.04% |
|
|
|
|
|
N/A |
0.00% |
35.82% |
17.19% |
---|
MREO |
Mereo BioPharma Group plc |
0 |
2.96% |
|
|
|
|
|
N/A |
0.00% |
265.92% |
22.72% |
---|
BSX |
Boston Scientific Corporation |
0 |
2.73% |
|
|
|
|
|
N/A |
0.00% |
28.78% |
27.76% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
2.56% |
|
|
|
|
|
N/A |
0.00% |
32.01% |
17.21% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
0 |
2.56% |
|
|
|
|
|
N/A |
0.00% |
37.64% |
23.71% |
---|
MASI |
Masimo Corporation |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
33.43% |
15.63% |
---|
EW |
Edwards Lifesciences Corporation |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
24.72% |
24.37% |
---|
MLYS |
Mineralys Therapeutics, Inc. |
0 |
2.18% |
|
|
|
|
|
N/A |
0.00% |
65.48% |
-0.68% |
---|
PODD |
Insulet Corporation |
0 |
2.10% |
|
|
|
|
|
N/A |
0.00% |
29.15% |
12.22% |
---|
MDT |
Medtronic plc |
0 |
2.05% |
|
|
|
|
|
N/A |
0.00% |
20.47% |
24.19% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
1.99% |
|
|
|
|
|
N/A |
0.00% |
33.62% |
26.98% |
---|
GPCR |
Structure Therapeutics Inc. |
0 |
1.89% |
|
|
|
|
|
N/A |
0.00% |
63.80% |
44.05% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
1.71% |
|
|
|
|
|
N/A |
0.00% |
50.78% |
12.70% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
1.71% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
4.48% |
---|
MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
1.66% |
|
|
|
|
|
N/A |
0.00% |
54.01% |
30.02% |
---|
RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
1.57% |
|
|
|
|
|
N/A |
0.00% |
179.98% |
66.59% |
---|
WST |
West Pharmaceutical Services, Inc. |
0 |
1.56% |
|
|
|
|
|
N/A |
0.00% |
29.33% |
12.58% |
---|
NTLA |
Intellia Therapeutics, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
94.17% |
49.29% |
---|
AKRO |
Akero Therapeutics, Inc. |
0 |
1.33% |
|
|
|
|
|
N/A |
0.00% |
41.17% |
11.80% |
---|
ZEAL.CO |
ZEALAND PHARMA A/S |
|
1.33% |
|
|
|
|
|
|
|
|
|
---|
NOVN.SW |
NOVARTIS AG |
|
1.31% |
|
|
|
|
|
|
|
|
|
---|
VKTX |
Viking Therapeutics, Inc. |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
69.67% |
14.07% |
---|
NARI |
INARI MEDICAL, INC. |
|
1.15% |
|
|
|
|
|
|
|
|
|
---|
INSM |
Insmed Incorporated |
0 |
1.09% |
|
|
|
|
|
N/A |
0.00% |
35.77% |
3.33% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
0 |
0.93% |
|
|
|
|
|
N/A |
0.00% |
74.69% |
27.30% |
---|
GUBRA.CO |
GUBRA A/S |
|
0.92% |
|
|
|
|
|
|
|
|
|
---|
SLNO |
Soleno Therapeutics, Inc. |
0 |
0.87% |
|
|
|
|
|
N/A |
0.00% |
90.12% |
36.31% |
---|
KROS |
Keros Therapeutics, Inc. |
0 |
0.86% |
|
|
|
|
|
N/A |
0.00% |
1,576.18% |
34.52% |
---|
VERV |
VERVE THERAPEUTICS, INC. |
|
0.79% |
|
|
|
|
|
|
|
|
|
---|
SLN |
Silence Therapeutics plc |
0 |
0.75% |
|
|
|
|
|
N/A |
0.00% |
178.98% |
38.64% |
---|
TERN |
Terns Pharmaceuticals, Inc. |
0 |
0.68% |
|
|
|
|
|
N/A |
0.00% |
110.00% |
42.94% |
---|
CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
227.58% |
65.75% |
---|